(Finance) – “The debate on cell -based products and precision fermentation is increasingly taking foot internationally. In recent months, two requests for authorization for sale in the European market of cellular products have come to the European Food Safety Authority (EFSA). Andrea Fabbri, Member of the Scientific Committee Foundation Aletheia explaining that he had participated in the Interministerial Table summoned by the Ministry of Health in concert with the Ministry of Agriculture and Food Sovereignty and Forests on this theme “as interesting as he is delicate”.
The reference framework for the evaluation is the legislation on Novel Food. To guide the comparison – he explains – “a single goal, to try to clarify laboratory foods and on precision fermentation products”.
This first phase of comparison of the table, whose results are published on the ministerial website, “has led us to support the importance of more insights since to date they do not have sufficient data to be able to say whether these new products are ‘safe’ and ‘healthy’ or they can instead be harmful. To do this, in-depth studies of a pre-clinical and clinical faces are needed In particular, to verify the effects on the intestinal microbiota and on the metabolism and capable of avoiding damage and pathologies for man “.
“I am convinced that science will be able to give us adequate answers and I am equally convinced That if it really can understand that these are safe and above all healthy products we will witness an epochal turning point. For now I don’t feel like saying this, there is still a lot to study and so much to deepen from a scientific and medical point of view. We owe it to the health of citizens “, he concludes Fabbri.